Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
I-Mab Biopharma
Press release submission
| Aug 1, 2019
I-MAB BIOPHARMA: I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors
Trending
+
Pharmaceuticals
Patient Daily
| May 1, 2024
Asthma Awareness Month: American Lung Association Focuses on Addressing Challenges of Extreme Heat and Asthma
+
Technology/Innovation
Patient Daily
| Apr 30, 2024
Co-founder of Binance: Medical research is currently 'too profit driven'
+
Pharmaceuticals
Patient Daily
| Apr 30, 2024
Unruly Sports Parents’ Effect on Children’s Mental Health
+
Pharmaceuticals
Patient Daily
| Apr 26, 2024
White House’s Further Delay of Rule to End Menthol Cigarettes Will Mean More Deaths